Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-04 @ 8:25 AM
Study NCT ID:
NCT03904251
Status:
TERMINATED
Last Update Posted:
2023-11-18
First Post:
2019-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Sponsor:
Jonsson Comprehensive Cancer Center